4//SEC Filing
LI WILLIAM 4
Accession 0001104659-22-011054
CIK 0001509745other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 9:49 PM ET
Size
5.6 KB
Accession
0001104659-22-011054
Insider Transaction Report
Form 4
LI WILLIAM
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-01-31+55,000→ 55,000 totalExercise: $1.94Exp: 2032-01-30→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of 4 quarterly installments until the Option is fully vested, with the first such quarterly installment vesting on the three-month anniversary of January 1, 2022, the Vesting Start Date.
Documents
Issuer
LEAP THERAPEUTICS, INC.
CIK 0001509745
Entity typeother
Related Parties
1- filerCIK 0001273806
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 9:49 PM ET
- Size
- 5.6 KB